Company / Interest Expense
Arcus Biosciences, Inc. Interest Expense History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$9.0M
FY2025
5-year range
$2.0M / $9.0M
FY2024-FY2025
Trend
+350.0%
vs FY2024
Sector context
#29 of 44
Health Care
What the data says
At $9M, Arcus Biosciences, Inc.'s interest expense ranks #16 of 44 in the Health Care sector.
Based on SEC 10-K filings.
$9M in FY2025.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#16 of 44 in Health CareTop 34% of 44This company $9.0M Sector average $291.0M
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, interest expense increased 350.0% year-over-year.
- Ranks #29 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.0M | +350.0% |
| FY2024 | $2.0M | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026